IMM 20.3% 35.5¢ immutep limited

ann: positive interim data from can-003 trial, page-11

  1. 15,518 Posts.
    lightbulb Created with Sketch. 43
    Shaneshanes

    The announcement just released today is the news we have been expecting. It is being presented by Dr Goh at the ICGS conference as a poster (as also released to the market) tomorrow our time.

    The only other thing we are currently awaiting is the release of the full 7 cohort ICS study, which could come any time, but today's ann gave a preview if that already, based on 3 patient results.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.